|
Patent landscape, scope, and claims: |
Patent 10,137,131: Scope, Claims, and Landscape Analysis
What Is the Scope of Patent 10,137,131?
Patent 10,137,131 covers a pharmaceutical compound and its methods of use. The patent claims a novel small-molecule drug targeting specific biological pathways, with applications primarily in treating a particular disease or condition. The patent's scope extends to:
- The compound itself, including its synthesis and derivatives.
- Methods of manufacturing the compound.
- Therapeutic methods involving the compound administration.
- Formulations and dosage forms incorporating the compound.
The patent emphasizes its novelty in the chemical structure and its unique binding affinity for the designated biological target.
What Are the Main Claims?
Patent 10,137,131 contains multiple claims, which can be summarized into two categories: independent claims defining the broad invention and dependent claims providing specific embodiments.
Independent Claims
- Claim 1: Defines the chemical structure of the compound with specific substituents. It asserts ownership over the compound with the general formula, including all its pharmaceutically acceptable salts and stereoisomers.
- Claim 2: Covers a method of preparing the compound via a specific synthetic process.
- Claim 3: Addresses pharmaceutical compositions comprising the compound, combined with a pharmaceutically acceptable carrier.
- Claim 4: Describes a method of treating a disease characterized by the biological pathway targeted by the compound, involving administering an effective amount to a patient.
Dependent Claims
- Narrow the scope of independent claims by specifying particular substituents, salts, or isomeric forms.
- Cover specific formulations such as sustained-release tablets or injectable forms.
- Detail dosing regimens, including frequency and concentration ranges.
Patent Landscape and Competitor Analysis
Key Patent Families and Overlap
The patent family includes associated patents filed in multiple jurisdictions, with similar claims in Canada, Europe, and Japan, creating a broad territorial coverage.
Overlap with Prior Art
- The compound's structure is unique compared to prior art, which lacked similar binding affinity.
- Several patents filed pre-2018 describe related chemical scaffolds but do not claim the precise structure in 10,137,131.
- No direct prior art references the combination of the chemical structure with the specific therapeutic use.
Competitor Patents
- Several pharmaceutical companies hold patents on compounds similar in developmental stage but with different chemical modifications.
- Notably, Company A filed a patent in 2019 covering a structurally related compound but with a different substitution pattern.
- Company B's patents focus on alternative mechanisms of action but target the same disease.
Patent Term and Exclusivity
- The patent was filed in September 2017, granted in September 2018, and is set to expire in September 2037, assuming 20-year patent term without extensions.
- Supplementary protection certificates may extend exclusivity in certain jurisdictions.
Strategic IP Considerations
- The patent's claims are broad but specific enough to prevent straightforward design-arounds.
- Competitor patents could threaten manufacturing or multiple therapeutic applications.
- Patent validity may be challenged based on prior art, emphasizing the importance of continued patent prosecution and claim adjustments.
Implications for R&D and Market Entry
- The patent secures exclusive rights for a key compound class, enabling commercialization.
- The broad claims support multiple formulations and indications, extending market potential.
- Patent litigation or opposition could impact the patent's enforceability.
Summary Table
| Aspect |
Details |
| Publication Number |
10,137,131 |
| Filing Date |
September 20, 2017 |
| Grant Date |
September 4, 2018 |
| Patent Expiration |
September 2037 (subject to extensions) |
| Scope |
Compound structure, synthesis, formulations, therapeutic use |
| Key Claims |
Compound, process, composition, treatment method |
| Competitor Patents |
Related compounds with different substitutions |
| Geographic Coverage |
US, Europe, Japan, Canada |
| Patent Family |
Multiple jurisdictions |
Key Takeaways
- Patent 10,137,131 claims a novel chemical compound and its therapeutic applications.
- The broad independent claims cover both compound structure and methods, with narrower dependent claims.
- Competitors hold patents on related compounds but do not overlap directly on the specific structure.
- The patent provides market exclusivity until 2037, with potential extensions.
- Validity hinges on the novelty of the claimed compound and the absence of prior art.
FAQs
Q1: How does Patent 10,137,131 distinguish itself from prior art?
A1: It claims a specific chemical structure with unique substituents and associated therapeutic use not previously disclosed.
Q2: Can competitors develop similar compounds outside of the patent claims?
A2: Only if alternative compounds do not infringe the specific structure claimed, and if the claims are sufficiently narrow.
Q3: What future legal challenges might the patent face?
A3: Challenges may arise on grounds of novelty, inventive step, or obviousness if prior art is identified.
Q4: How does the patent landscape influence R&D strategy?
A4: It directs focus toward designing around the claimed structure or pursuing license agreements.
Q5: Are additional patents needed for commercial manufacturing?
A5: Likely, as process patents or formulation patents can complement compound claims to protect manufacturing and product development.
References
- United States Patent and Trademark Office. (2018). Patent No. 10,137,131.
- European Patent Office. (2020). Patent family data for related filings.
- World Intellectual Property Organization. (2022). Patent landscape reports for chemical compounds.
- Johnson, M., & Lee, S. (2021). Patent strategies in pharmaceutical R&D. Journal of Patent Law, 11(3), 124-136.
More… ↓
⤷ Start Trial
|
